HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resistance of SJL mice to immunosuppression by antibodies.

Abstract
Immunosuppressive antisera that specifically inhibit induction of tuberculin-type delayed hypersensitivity in mice to the antigens chicken conalbumin and methylated human serum albumin were compared for activity in CF-1, CAF1, and SJL mice. These contrasensitizing antisera were effective in CF-1 and CAF1 mice of various ages. But in SJL mice they were ineffective if the animals were older than 8 weeks and were only moderately effective if the animals were younger. The antibodies of these antisera responsible for specific immunosuppression could be absorbed onto adherent peritoneal exudate cells taken from DAF1 but not SJL mice. They could be eluted from the CAF1 cells at 56 degrees C. These results and other data that are discussed suggest that SJL resistance to immunosuppression by contrasensitizing antibodies is related to a macrophage abnormality. The results also help explain earlier findings that SJL mice are unusually easy to sensitize and unusually resistant to tolerogenesis. This strain of mice should be especially useful for studying the mechanisms of afferent immunosuppression in immunologic enhancement-like forms of tolerance.
AuthorsA J Crowle, S Jacobson, M May
JournalImmunological communications (Immunol Commun) Vol. 7 Issue 4 Pg. 417-29 ( 1978) ISSN: 0090-0877 [Print] United States
PMID669750 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens
  • Immune Sera
  • Serum Albumin
  • Conalbumin
Topics
  • Aging
  • Animals
  • Antigens
  • Conalbumin (immunology)
  • Female
  • Hypersensitivity, Delayed
  • Immune Sera (pharmacology)
  • Immunosuppression Therapy
  • Mice
  • Mice, Inbred Strains (immunology)
  • Serum Albumin (immunology)
  • Species Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: